ArticlePDF AvailableLiterature Review

Effectiveness of non-operative methods of treatment of carpal tunnel syndrome: a narrative review

Authors:

Abstract and Figures

Introduction. Carpal tunnel syndrome (CTS) can be treated with several methods, including surgical and non-surgical techniques. Non-surgical methods include wrist splinting, systemic pharmacotherapy, intracarpal injections of steroids hydrodissection, acupuncture, nerve and tendon mobilization, osteopathy, taping, topical application of ointments, laser, ultrasound and shock-wave therapies. These treatments are generally less effective than surgery, and provide only short-lived effect, but it may be quite sufficient for a certain category of patients, particularly those suffering from mild symptoms. Over the last years, these techniques have attracted increasing popularity, because they offer non-invasive option for surgical treatment what can be attractive for some patients. However, although these methods were shown in the literature, their actual effectiveness has not been scientifically verified. The objective of this study was a review of the effectiveness of non-operative methods of treatment of CTS. Methods. A review of the published literature from PubMed and Medline databases on the effectiveness of CTS non-operative treatments of was done. Results. The review indicates that each of the presented methods is effective in reduction of symptoms and improvement of hand function in CTS patients, but their effect is only short-lived. None of these treatments provides a permanent cure, like does surgical treatment. Conclusion. In spite of numerous non-operative treatments of CTS, surgery is the only method that provides permanent recovery.
Content may be subject to copyright.
2536
© Aluna Publishing
Wiadomości Lekarskie Medical Advances, VOLUME LXXVII, ISSUE 12, DECEMBER 2024
INTRODUCTION
Carpal tunnel syndrome (CTS) is caused by compression
of the median nerve in the carpal tunnel. It is the most
common compression neuropathy, aecting 1-1.5% of
the total population and about 6% of women over 40
years of age. Middle-aged and elderly women are the
largest group aected by this condition. The age of
onset varies: in the clinic managed by the author, the av-
erage age of women admitted for carpal tunnel release
was 57 years. Although several predisposing factors are
known (diabetes, hypothyroidism, rheumatoid arthri-
tis), in about 80% of cases the cause of the syndrome
cannot be determined (an idiopathic syndrome) [1-8].
Carpal tunnel syndrome can be treated with several
methods [1, 2, 6, 7]. Although surgical treatment (cut-
ting of exor retinaculum) is most often used, other,
non-surgical methods have their place in the CTS
management. These include immobilization of the
wrist joint in a splint or orthosis, various methods of
physiotherapy, systemic pharmacotherapy and local in-
jections of steroids. Conservative treatment is generally
considered to be less eective than surgery and only
temporary eective, but it may be quite sucient for a
certain category of patients, particularly those suering
from mild symptoms. Over the last years, non-operative
methods of treating carpal tunnel syndrome have to be
oered, such as: hydrodissection, acupuncture, nerve
and tendon mobilization, osteopathy, taping, topical
application of ointments, as well as laser, ultrasound and
shock-wave therapies. These techniques have attracted
increasing popularity, because they oer non-invasive
option for surgical treatment what can be attractive
for some patients. However, although these methods
were shown in the literature, their actual eectiveness
has not been scientically veried.
AIM
The objective of this study was to review an eective-
ness of non-operative methods of the treatment of
carpal tunnel syndrome.
MATERIAL AND METHODS
This article presents a review of the published literature
from PubMed and Medline databases on the eec-
Eectiveness of non-operative methods of treatment of carpal
tunnel syndrome: a narrative review
Andrzej Żyluk1, Alicja Żyluk2
1DEPATRMENT OF GENERAL AND HAND SURGERY, POMERANIAN MEDICAL UNIVERSITY, SZCZECIN, POLAND
2
DEPARTAMENT OF GENERAL NAD HAND SURGERY, STUDENT’S SCIENTIFIC CIRCLE, POMERANIAN MEDICAL UNIVERSITY, SZCZECIN, POLAND
ABSTRACT
Carpal tunnel syndrome (CTS) can be treated with several methods, including surgical and non-surgical techniques. Non-surgical methods include wrist splint-
ing, systemic pharmacotherapy, intracarpal injections of steroids hydrodissection, acupuncture, nerve and tendon mobilization, osteopathy, taping, topical
application of ointments, laser, ultrasound and shock-wave therapies. These treatments are generally less eective than surgery, and provide only short-lived
eect, but it may be quite sucient for a certain category of patients, particularly those suering from mild symptoms. Over the last years, these techniques
have attracted increasing popularity, because they oer non-invasive option for surgical treatment what can be attractive for some patients. However, although
these methods were shown in the literature, their actual eectiveness has not been scientically veried. The objective of this study was a review of the
eectiveness of non-operative methods of treatment of CTS. A review of the published literature from PubMed and Medline databases on the eectiveness of
CTS non-operative treatments of was done. The review indicates that each of the presented methods is eective in reduction of symptoms and improvement
of hand function in CTS patients, but their eect is only short-lived. None of these treatments provides a permanent cure, like does surgical treatment. In spite
of numerous non-operative treatments of CTS, surgery is the only method that provides permanent recovery.
KEY WORDS: carpal tunnel syndrome, non-operative treatment, outcomes of the treatment, literature review
Wiad Lek. 2024;77(12):2536-2545. doi: 10.36740/WLek/196561 DOI
REVIEW ARTICLE CONTENTS
Eectiveness of non-operative methods of treatment of carpal tunnel syndrome: a narrative review
2537
tiveness of non-operative treatments of carpal tunnel
syndrome. A randomized clinical trials, systematic
reviews and meta-analyses reporting on use of these
methods were reviewed. Keywords used at searching
articles were: carpal tunnel syndrome, non-operative
treatment, clinical outcomes, treatment eectiveness,
systematic review, meta-analysis and treatment com-
plications.
REVIEW AND DISCUSSION
The results of the literature review will be presented
separately for each non-standard treatment. First three
paragraphs will end with the author’s comment on the
results presented.
HYDRODISSECTION
USG-guided injection (also named as hydrodissection
or perineural injection) delivering a range of injec-
tates, i.e. normal saline, corticosteroids, dextrose and
platelet-rich plasma attracts growing popularity in the
treatment of CTS [9-13]. In assumption, this procedure,
provides a mechanical eect to release and decompress
the entrapped nerves and adds a pharmacological
eect of delivered drug relieving pain and promoting
recovery. During hydrodissection, ultrasound guidance
is used to identify the nerve and guide the needle to the
nerve. After this, an adequate volume of an injectate is
placed around the nerve to separate it from surround-
ing tissue, fascia, or adjacent structures that may be
compressing the nerve. The volume of uid injected
into carpal tunnel varies from 4 to 10 ml.Depending
on the patient, only one treatment may be needed,
but this procedure typically needs to be repeated 2-3
times to achieve the expected result.
Several publications presenting eectiveness of this
procedure using various injectates were published [9-
13]. Most studies compared dierent ultrasound-guid-
ed interventions to dierent comparison injectate or
other conservative treatments such as wrist splinting
or physical therapy, but none compared a matched
intervention and comparison groups. Various injectates
were used such as 0,9% saline solution, 5% dextrose
solution, corticosteroids, local anaesthetics, hyaluronic
acid, platelet-rich plasma and ozone. Outcome mea-
sures after intervention included pain intensity in the
Numeric Rank Scale (NRS, range 0-10, higher means
stronger pain), Boston Carpal Tunnel Questionnaire
(BCTQ; range 1-5, higher means worse symptoms and
greater disability) and Disability of Arm, Shoulder and
Hand questionnaire (DASH; range 0-100, higher means
greater disability) as well as the electrodiagnostic stud-
ies. Results reported in these studies show generally
good results after hydrodissection procedure using
various injectates, in terms of cessation of pain, clinical
improvement (decreasing of BCTQ and DASH scores)
and improvement of electrodiagnostic parameters.
All considered variables were statistically signicantly
better after treatment, comparing to baseline [10, 11].
Yang et al. reported results of investigations of ef-
cacy of various injectates used in hydrodissection
procedures in the treatment of carpal tunnel syndrome
through a network meta-analysis of randomized control
trials. Platelet-rich plasma was identied to be the most
eective injectant for short-term functional improve-
ment and pain relief. Platelet-rich plasma is the pro-
cessed liquid fraction of autologous peripheral blood
with a platelet concentration. The authors conclude
that results of their network meta-analysis show that
platelet-rich plasma can be used as rst-line treatment
for carpal tunnel syndrome, and other injectates such
as 5% dextrose and steroids may serve as alternative
treatments [13].
Interestingly, favourable outcomes after hydrodissec-
tion procedure were observed also in a control groups
using injections with plain saline or local anaesthetics;
unfortunately there were no clear placebo-controlled
trials. However considering normal saline injection as
placebo, these results may suggest that hydrodissection
itself results in clinical improvement, regardless the
injectate used [9, 11, 12]. No serious adverse events
were reported after hydrodissection. Results of the
analysis of literature on use of this procedure show that
USG-guided hydrodissection is a safe but only tempo-
rary eective treatment for mild to moderate CTS. A
major rationale for using this technique is to reduce the
risk of iatrogenic nerve injury during blind intracarpal
injection of various substances.
CRITICAL COMMENT
Current evidence supporting use of hydrodissection for
carpal tunnel syndrome has a signicant drawback: a
short follow-up. Almost all studies presented results up
to 6 months! There may be concern that after a longer
time the symptoms may return in most patients. In
essence, hydrodissection does not dier much from
ordinary steroid or hyaluronic acid injections. Although
it is ultrasound-guided and more uid is injected into
the carpal tunnel, but the procedure does not change
anatomical relations in the carpal tunnel. The only
procedure that changes the anatomical relations in the
carpal tunnel is surgical cutting the exor retinaculum.
When all structures in the carpal tunnel remain unchan-
ged, it is dicult to assume that the pressure on the me-
Andrzej Żyluk, Alicja Żyluk
2538
dian nerve, which was reduced after the intervention,
will not return after a shorter or longer period of time.
Therefore benecial eect of hydrodissection repor-
ted in many studies should be treated with caution as
potentially short-lived. The reviewed literature also did
not provide any evidence that patients with CTS who
underwent hydrodissection will avoid surgery in the
future.Therefore the assurances of some doctors that
hydrodissection is as eective treatment as surgery and
without unpleasant adverse eects are unfair.
STEROID INJECTION
Intracarpal steroid injection is one of the most common-
ly accepted treatment among the various conservative
managements for CTS. There are several supposed
mechanisms of action of local steroids in carpal tunnel
syndrome, including:
Anti- inammatory eect by inhibiting the produc-
tion of inammatory cytokines by lymphocytes and
macrophages in the tenosynovium.
Antibrotic eect via the suppression of collagen
expression.
Anti-oedematous eects through reduced vascular
permeability.
Activation of all these mechanisms results in a bene-
cial eect in the form of cessation of symptoms and
improvement of hand function [13-17]. In some studies
an improvement in electrophysiological parameters in
the median nerve has also been observed [15, 17]. Basi-
cally 3 substances are used for injections: triamcinolone,
methylprednisolone and betamethasone. Eectiveness
all these injectates is similar and their use depends
mainly on the individual surgeon’s preference. Steroids
are injected into carpal tunnel with landmark-guided
technique or with USG guidance; the former technique
is much more common, but it carries some risk of in-
traneural injection, even with correct needle insertion
and localization. Therefore, ultrasound-guided injection
is gradually applied for accurate localization of intracar-
pal structures. However, landmark-guided injection still
seems to be one of the most available management
procedures, attributed to good eectiveness, more
convenience, and lower cost [17].
In general 1-3 injections at 2-4 week intervals are
needed to achieve permanent improvement, but some
patients respond excellently to one injection. Steroid
injections provide a very quick relief of symptoms,
usually within 24 hours after the injection, which is
why patients often ask for such treatment. This applies
especially to patients with severe symptoms who are
referred for surgical treatment, but their waiting time
is long, i.e. several weeks or months.
There is abundant literature on steroid injections for
carpal tunnel syndrome. We provide reviews of only
several studies.
Marshall et al., presented results of systematic review
of on the ecacy of local steroid injections in carpal tun-
nel syndrome [14]. They included 12 studies involving
altogether 671 participants. Results of this analysis show
Fig. 1. Application of shock wave in
carpal tunnel syndrome.
Eectiveness of non-operative methods of treatment of carpal tunnel syndrome: a narrative review
2539
are very satisfied with such therapy. It is safe and
cheap, unlike other, non-operative treatments, which
are usually much more expensive and similarly (or
less) eective. The method is safe, both when given
with landmark-guided method or with USG guidance.
Steroid injection also has diagnostic value: in doubtful
cases, signicant improvement after steroid injection
conrms diagnosis of carpal tunnel syndrome and that
surgical treatment should be eective.
SPLINTING
Among the non-operative treatment modalities
splinting has emerged as a rst-line treatment in mild
to moderate CTS [18-23]. Splints are typically recom-
mended for use at night, but may also be worn during
daytime hours depending on patient work and activity
demands. By maintaining the wrist in a neutral posi-
tion, splints prevent the extremes of wrist exion and
extension, which have been shown to increase pressure
within the carpal tunnel, irritate the median nerve and
causes symptoms. Most of splints only immobilize the
wrist, but some extend distally and keep the metacar-
pophalangeal joints extended. This (theoretically) pre-
vents the lumbrical muscles from proximal migration
and entering the carpal tunnel. There are many studies
in the literature supporting the use of splints in mild to
moderate CTS. Older studies reported signicant bene-
cial eect of splinting. Manente et al. (2001) reported
signicant reduction of nocturnal symptoms (pain and
numbness) and functional improvement, after use of a
soft hand splint at night for 4 weeks, when compared
with a control group [18]. Other studies reported similar
benets from splinting [19-22].
However, an updated meta-analysis of the literature
by Karjalainen et al. showed dierent picture. Results
of recent studies showed that night splinting provides
little or no benets in reduction of symptoms in the
short term (< 3 months) and does not improve hand
function in the short and long term (> 6 months). In
the short and long term, the mean BCTQ was 0,24
points better after splinting compared with no active
treatment. The Minimal Clinically Important Dierence
(MCID) for BCTQ is 0,7 points, what means that this im-
provement was not clinically meaningful. Nevertheless,
these variables were better after splinting compared to
before treatment [23].
An assessment of ecacy of splinting as an additional
treatment to steroid injection, rehabilitation, kinesiol-
ogy taping, rigid taping or extracorporeal shock wave
treatment (ESWT) showed that splinting does not pro-
vide additional benets in reduction of symptoms or
improvement of hand function when given together
that in most studies steroid injection provides greater
symptom relief one month after injection, compared to
placebo, however this eect was short-living and was
not demonstrated beyond one month. Other ndings
from this study are as follows: steroid injection provides
signicantly greater clinical improvement than oral
corticosteroid for up to three months; steroid injec-
tion does not signicantly improve clinical outcome
compared to either anti-inammatory treatment and
splinting after two months or laser treatment after
6 months; two local corticosteroid injections do not
provide signicant added clinical benet compared to
one injection [14].
In a more recent study, Ashworth et al. presented
results of Cochrane database systematic review of pla-
cebo-controlled studies investigating the ecacy of
local steroid injections for CTS [15]. The authors found
14 trials with 994 participants. The main conclusion
from this analysis is that intracarpal steroid injections
are eective for the treatment of mild and moderate
CTS with benets lasting up to six months. Another
nding is that this therapy reduces need for surgical
treatment of the syndrome up to 12 months. All studies
reported a very low risk of serious adverse events [15].
Similar conclusions were presented in study by Yang
et al., (2024), who presented results of a systematic
review and network meta-analysis of randomized con-
trolled trials on the eectiveness of injection therapy
using various injectables for CTS. In the part relating
to the use of steroids these authors state that steroid
injections are eective in terms of symptom and pain
relief as well as functional improvement in the short
term (up to 6 months) but not in the long term [13].
Kaile et al., reported results of the study investigating
safety of landmark-guided steroid injections with 40 mg
triamcinolone for CTS. These authors have encountered
only 4 serious complications in 9515 injections. At
routine follow-up, 6 weeks after injection 33% patients
reported some side eects, the most commonly it was
short-lived local pain (13%) which resolved in all cases
within 3 weeks. No cases of intraneural injection or
tendon rupture occurred. Most adverse eects were
transient, only 13 hands exhibited persistent skin de-
pigmentation or subcutaneous atrophy. The authors
conclude that landmark-guided intracarpal steroid
injection is safe procedure, burdened with a very low
risk of complications [16].
CRITICAL COMMENT
Intracarpal steroid injections are commonly used in
the treatment of CTS. Although it is well known that
it does not provide a permanent cure, many patients
Andrzej Żyluk, Alicja Żyluk
2540
disorders in which the laser is used. The most common
treatment protocol involved 5 laser sessions a week for
a total of 2-3 weeks. Three or 5 application points over
the course of the median nerve at the wrist was the
most commonly used action position. Dierent laser
irradiation energy doses were used, from 2,7 to 11 J
(Joule) for each point or as total energy from 81 to 300
J for the entire treatment [24, 26].
Results of older studies showed reduction of pain and
improvement of hand function in patients who received
2-3 weeks laser therapy, however all these studies were
uncontrolled [24, 25]. Li et al., (2016) reported results of
a meta-analysis of placebo-controlled studies published
in recent years. Results of these studies have shown
a short-term (3 months in average) benecial eects
of laser therapy on clinical and electrophysiological
parameters in the CTS. These ndings, however, were
not consistent because of dierent laser intervention
protocols used in these studies. Moreover, the func-
tional mechanism of low-level lasers is not clear, and
some studies suggested that laser irradiation did not
change the functional properties of peripheral nerves
[26]. The fundamental disadvantage of these studies
is very short follow-up period. Therefore benecial
eect of laser therapy reported in these studies should
be treated with caution as potentially short-lived. The
reviewed literature also did not provide any evidence
that patients with CTS who underwent laser therapy
will avoid surgery in the future.
ULTRASOUND THERAPY
Ultrasound (US) treatment within an intensity range
of 0,5 – 2,0 W/cm2 may have the potential to induce
various biophysical eects within tissue. The rationale
of using US therapy in carpal tunnel syndrome is based
on results of some studies which showed its benecial
eects such as an anti-inammatory eect, stimulation
of nerve regeneration via enhanced blood ow, and
membrane permeability, as well as improvement of
conduction properties in the nerve. Activation of these
mechanisms by US treatment might (in assumption)
facilitate recovery from nerve compression [27, 28].
Results of study by Ebenbichler et al., (1998) showed
that pulsed ultrasound at frequency of 1MHz, and
energy of 1,0 W/cm2 applied to the palmar side of the
wrist over 15 min for ten consecutive days, followed
by twice weekly treatments for ve additional weeks
resulted in cessation of pain and nocturnal paresthesiae,
improved sensation in the ngers innervated by the
median nerve, increased grip and pinch strength and
improved electrophysiological parameters. Treatment
eects were observed up to 6 months [27]. However,
with these measures. Results of some studies showed
that splinting for 12 weeks was not better than 6 weeks,
but 6 months of splinting was more benecial than 6
weeks of splinting in cessation of symptoms and im-
proving of hand function [23].
The evidence whether splinting benets patients with
carpal tunnel syndrome is not clearly convincing. This
means possibility of small improvements in symptoms
and hand function, but they may not be clinically mean-
ingful. Results of some studies suggest that patients
may experience overall improvement with night-time
splints comparing to no treatment. As splinting is sim-
ple, cheap and safe, even small eects could justify its
use, particularly when patients are afraid of more inva-
sive treatments. It is unclear if a splint is optimally worn
full time or at night-time only and whether long-term
use is better than short-term use, but some evidence
suggests that the benets may manifest in the long
term [19, 22].
CRITICAL COMMENT
Splinting is now considered an eective treatment for
mild CTS, devoid of adverse eects, although somewhat
inconvenient for patients. However, it should be stated
that it is a good method only for patients with mild
symptoms who do not feel discomfort during the day
and without impaired hand function. Such a clinical
presentation concerns only about 5% of patients, which
is a signicant minority. The author’s experience shows
that night splinting never results in full recovery and
almost all patients treated with this method are eventu-
ally operated on. Night splinting is also recommended
for the waiting time for surgery, which can take up to
several months. This allows patients survive the waiting
time in greater comfort. An intracarpal steroid injection
is similarly eective procedure used in patients who are
waiting for surgery and suer from severe pain.
OHER NONINVASIVE TREATMENTS.
Other, less commonly used non-invasive treatments will
be presented in short paragraphs, below.
LOW-LEVEL LASER THERAPY
The benecial eect of the low-level laser in CTS is (in
theory) achieved through several mechanisms, such
as increasing myelin production, anti-inammatory
eects, selective inhibition of nociceptive activation
at peripheral nerves, increased ATP production and
improvement of blood circulation in the median nerve
[24-26]. These mechanisms are also mentioned in other
Eectiveness of non-operative methods of treatment of carpal tunnel syndrome: a narrative review
2541
no additional placebo-controlled studies were available
to support the actual eect of US, with certain studies
calling its utility into question [21, 28]. Finally, Page
et al., (2013) presented results of Cochrane review of
studies presenting results of treatment of carpal tunnel
syndrome with ultrasound therapy and concluded that
there is only poor quality evidence from very limited
data to suggest that therapeutic ultrasound may be
more eective than placebo for either short- or long-
term symptom improvement in CTS patients. They also
stated that is insucient evidence to support the use
of therapeutic ultrasound as a treatment with greater
ecacy compared to other conservative treatments,
such as splinting, physiotherapy, steroid injections and
oral drugs [28].
ACUPUNCTURE
Acupuncture aims to stimulate trigger points along the
meridian, a proposed pathway of energy through the
body. Meridian is a concept from traditional Chinese
medicine. According to this concept, meridians form a
system of channels wrapping around the human body.
They connect to the organs of the body that play a key
role in the production, processing, and transmission of
energy called Qi. Optimizing this energy pathway is be-
lieved to have benecial eect in CTS without altering
mechanical pressures within the carpal tunnel [21]. The
mechanism of action of acupuncture remains unknown,
proposed theories include a neuromodulatory eect
on pain perception by promoting endogenous central
nervous system analgesic production and activating
anti-inammatory pathways [21, 29, 30].
In a recent Cochrane review compiling 12 studies and
869 patients, Choi et al. concluded that acupuncture
may have little or no short-term eect on CTS symp-
toms in comparison with placebo or sham procedures
[31]. This was largely attributed to heterogeneity of the
studies and the risk of bias. The authors also stated that
the adverse eects of acupuncture, such as skin bruising
and local pain after needle insertion, are inconsistently
reported among trials and must be documented to
comprehensively assess risks and benets prior to rec-
ommending treatment [31].
EXTRACORPOREAL SHOCK WAVE THERAPY
Extracorporeal shock wave therapy (ESWT) has been
used for the treatment of CTS as a novel and non-inva-
sive method (Fig. 1) [32-35]. The mechanism of action of
ESWT in carpal tunnel syndrome is not fully understood;
the proposed theories include the anti-inammatory
and neuronal regeneration eects as potential mode
of action. The anti-inammatory eect is similar to ob-
served in other musculoskeletal disorders treated with
ESWT. This eect on intracarpal structures can modulate
the perineural pressure and promote cessation of CTS
symptoms. Second proposed mechanism is induction
of peripheral nerve regeneration by accelerating the
elimination of the injured axon, increasing Schwann cell
proliferation, and increasing axonal regeneration. These
mechanisms can have eect on improvement of clinical
symptoms and electrophysiologic parameters [32, 33].
Xu et al., reported results of randomised study com-
paring the eect of ESWT vs steroid injection in mild
and moderate carpal tunnel syndrome. At the 3 months
follow-up, a statistically signicantly greater eect on
reduction of symptoms and improvement of function
was noted for the ESWT group than for the steroid injec-
tion group. For the nerve conduction study, there was a
signicant improvement in the median nerve sensory
nerve action potential distal latency at the 3 months
follow-ups for the ESWT group. The authors conclude
that ESWT is a useful non-invasive short-term treatment
for mild to moderate carpal tunnel syndrome and elicits
a better recovery than local steroid injection [33].
Kim et al., presented results of a systematic review
and meta-analysis of randomized controlled trials on
the eect of ESWT in carpal tunnel syndrome. These
authors found 6 studies meeting the requirements
for analysis, involving a total of 261 patients. Based on
results of this analysis they noted that ESWT treatment
improves symptoms, functional outcomes, and electro-
physiologic parameters in patients with CTS, however,
there was no obvious dierence between the ecacies
of ESWT and local corticosteroid injection. No serious
side eects were reported in all included studies [34].
In contrast, results of recent meta-analysis by Chen
et al., (2022) which involved 7 randomized controlled
trials with a total of 376 participants showed that at
the 3 months follow-up, the ESWT did not demonstrate
superior ecacy compared to treatment with night
wrist splinting alone. The authors conclude that the
therapeutic eect of ESWT is transient and mostly
nonsignicant [35].
SHORTVAWE AND ELECTROMAGNETIC
DIATHERMY
Diathermy is a therapeutic technique that produces
deep heating under the skin, muscles, and joints for
therapeutic purposes. It is classied into two types:
shortwave and microwave diathermy Recently, an elec-
tromagnetic diathermy has been introduced alongside
these categories. It is known as capacitive resistive
electric transfer and it can be considered as longwave
Andrzej Żyluk, Alicja Żyluk
2542
the mobility of the myofascial tissues adjacent to the
nerve. For CTS, the nerve gliding exercises are done
by alternately exion and extension of ngers with
dierent wrist positions and forearm in pronation and
supination [38, 39]. Tendon gliding exercises are done
by alternately exion and extension of all ngers and
thumb in metacarpophalangeal and interphalangeal
joints, making hook st, all nger joints in full exion
and full st [38, 39].
However, variability of manual techniques, lack of
terminology consensus and standardization in the
techniques whose aim is to mobilize the nervous
system raises doubts the actual eectiveness of these
techniques. Moreover, parameters such as the mobili-
zation dosages, the number of joints to be mobilized
and the consideration to stabilize or not the wrist joint
while performing the gliding mobilization techniques
are not uniform throughout the studies. These doubts
were highlighted in the study by Page et al. (2012) who
conducted a systematic review of studies presenting re-
sults of neural mobilization for carpal tunnel syndrome.
These authors concluded that there was limited and
very low quality evidence of benet for all of a diverse
collection of exercise and mobilisation interventions for
carpal tunnel syndrome. In most of reviewed studies
nerve mobilization techniques provided short-live im-
provement and only in mild CTS [40]. Therefore patients
who indicate a preference for exercise or mobilisation
interventions should be aware of the limited eective-
ness of this therapy.
KINESIOTAPING
Kinesiotaping is a therapeutic technique that pulls up
the skin and provides a space under the skin, directing
connective tissue to the expected area. Application of
this measure can control the pulling force to a certain
tendon or ligament to avoid further injury, so that
spontaneous tissue repair can be facilitated. It has been
hypothesized that kinesiotaping application, through
neural technique and space correction may be bene-
cial for patients with mild and moderate carpal tunnel
syndrome. Geler Kulcu et al. (2016) reported good
outcomes after use of kinesiotaping in 45 patients (65
wrists). The tape was applied at beginning of the week,
to stay on for 5 days, with a 2-day rest, for a total of
four times. At a nal follow-up, pain and paresthesiae
signicantly reduced and hand function signicantly
improved as assessed by Numeric Rank Scale and the
Boston Carpal Tunnel Questionnaire. The problem
with this study is that the authors did not provide the
follow-up period, therefore actual eect of this therapy
cannot be credibly evaluated [41]. In an another study, a
diathermy, as the wave frequency used is relatively
lower than those of shortwave and microwave. The
physiological eects of diathermy include an increase
in blood perfusion which facilitates tissue healing, a lo-
cal increase of oxygen and nutrients, improved muscle
contraction capacity, and a possible positive change in
pain sensation [36, 37]. Benecial eects of diathermy
could also be mediated at a central nervous system. Re-
sults of functional MRI studies showed central eects of
skin warming, with increased activation of the posterior
insula and thalamus of the brain which promoted pain
relief in the peripheral body parts [37].
Several studies are available investigating an eect
of diathermy in carpal tunnel syndrome.
Incebiyik et al., reported results of a randomized clin-
ical trial involving 31 CTS patients who were assigned
randomly to 2 treatment groups: rst received a hot
pack, shortwave diathermy, nerve and tendon gliding
exercises (treatment group) and second which received
a hot pack, placebo diathermy, nerve and tendon
gliding exercises (control group). The treatment was
applied ve times weekly for a total of 15 sessions. At
the one-month follow-up, improvement (cessation of
symptoms, better hand function) was observed in both
groups, however only in the treatment group it was
statistically signicantly better than at baseline [36].
Pollet et a., presented results of a systematic review
with meta-analysis on efficacy of electromagnetic
diathermy for the treatment of musculoskeletal disor-
ders, including CTS, based on 68 studies included in
the analysis. Many pathologies were treated with dia-
thermy against placebo. The analysed studies showed
controversial results and most of them did not show
signicant improvements in the primary outcomes.
The authors conclude that results of current evidence
does not conrm that diathermy or electromagnetic
diathermy can be considered an eective therapy in
musculoskeletal disorders, including CTS [37].
NEURAL MOBILIZATION
This method generally consists of techniques termed
neural glides, neural ossing or neural stretching.
The main objectives of neural mobilisation is to facili-
tate the gliding of tendons and nerves within the carpal
tunnel in order to maximize nerve and tendon excursion
to improve axonal transport and nerve conduction [38-
40]. Some joint mobilizations described as transverse
and ventral glide on dorsal side of the rst carpal row
were designed to release carpal tunnel syndrome by
increasing cross-sectional area of the carpal tunnel.
In addition, soft tissue mobilization aims to reduce
pressure on the carpal tunnel syndrome by improving
Eectiveness of non-operative methods of treatment of carpal tunnel syndrome: a narrative review
2543
indicates that only operative treatment by cutting the
exor retinaculum changes the anatomical relations in the
carpal tunnel and ensures a permanent cure. It is obvious
that surgery is burdened with a certain risk of complica-
tions, but this risk is disproportionately small in relation
to the benets achieved. Therefore, without denying the
legitimacy of non-surgical therapies in some patients and
in some situations, it must be clearly stated that scientic
evidence from reliable scientic publications clearly indi-
cates surgical treatment as ensuring permanent recovery
from the disease. Therefore, the statements sometimes
found in advertisements of some private clinics that one
of the new methods of non-surgical treatment is the same
eective as surgery, but without unpleasant adverse ef-
fects are unjustied and unfair.
benecial eect of kinesiotaping combined with splint-
ing was shown [42]. However, it should be stated that
this method, although simple and safe, is not popular as
a basic treatment and does not constitute a signicant
alternative to the previously discussed, much better
known techniques.
CONCLUSIONS
The review of non-operative treatments of CTS presented
in this paper indicates that each of the presented methods
provide only short-live improvement and none of them
provides a permanent cure. The multitude of these meth-
ods is only a conrmation of this fact. Current scientic
evidence on the eectiveness of various CTS treatments
REFERENCES
1. Bland JD. Carpal tunnel syndrome. BMJ. 2007 Aug 18;335(7615):343-6. doi: 10.1136/bmj.39282.623553.AD. DOI
2. Padua L, Coraci D, Erra C, et al. Carpal tunnel syndrome: clinical features, diagnosis, and management. Lancet Neurol. 2016 Nov;15(12):1273-
1284. doi: 10.1016/S1474-4422(16)30231-9. DOI
3. Puchalski P, Zyluk P, Szlosser Z, Zyluk A. Factors involved in the clinical prole of carpal tunnel syndrome. Handchir Mikrochir Plast Chir.
2018 Feb;50(1):8-13. doi: 10.1055/a-0572-7121. DOI
4. Żyluk A. Carpal tunnel syndrome in pregnancy: a review. Pol Orthop Traumatol. 2013 Oct 7;78:223-7.
5. Żyluk A. Is carpal tunnel syndrome an occupational disease? A review. Pol Orthop Traumatol. 2013 May 27;78:121-6.
6. Żyluk A, Szlosser Z. Ultra mini-invasive sonographically guided carpal tunnel release: a preliminary report. Chir Narzadow Ruchu Ortop
Pol., 2019; 84(5) 136-140. doi: 10.31139/chnriop.2019.84.5.28 DOI
7. Elsharif M, Papanna M, Helm R. Long-term follow up outcome results of Knifelight carpal tunnel release and conventional open release
following a departmental randomized controlled trial. A prospective study. Pol Orthop Traumatol. 2014 May 29;79:67-70.
8. Zyluk A, Skała K. Hand disorders in the course of systemic and chronic diseases: a review. Pol Orthop Traumatol. 2014 Apr 2;79:30-6.
9. Buntragulpoontawee M, Chang KV, Vitoonpong T, Pornjaksawan S, Kitisak K, Saokaew S, Kanchanasurakit S. The eectiveness and safety
of commonly used injectates for ultrasound-guided hydrodissection treatment of peripheral nerve entrapment syndromes: a systematic
review. Front Pharmacol. 2021 Mar 5;11:621150. doi: 10.3389/fphar.2020.621150 DOI
10. Lam KHS, Hung CY, Chiang YP, Onishi K, Su DCJ, Clark TB, Reeves KD. Ultrasound-guided nerve hydrodissection for pain management: rationale,
methods, current literature, and theoretical mechanisms. J Pain Res. 2020 Aug 4;13:1957-1968. doi: 10.2147/JPR.S247208 DOI
11. Lam KHS, Wu YT, Reeves KD, Galluccio F, Allam AE, Peng PWH. Ultrasound-guided interventions for carpal tunnel syndrome: a systematic
review and meta-analyses. Diagnostics (Basel). 2023 Mar 16;13(6):1138. doi : 10.3390/diagnostics13061138 DOI
12. Cass SP. Ultrasound-guided nerve hydrodissection: what is it? a review of the literature. Curr Sports Med Rep. 2016 Jan-Feb;15(1):20-2.
doi: 10.1249/JSR.0000000000000226 DOI
13. Yang FA, Wang HY, Kuo TY, Peng CW, Liou TH, Escorpizo R, Chen HC. Injection therapy for carpal tunnel syndrome: A systematic review and
network meta-analysis of randomized controlled trials. PLoS One. 2024 May 16;19(5):e0303537. doi: 10.1371/journal.pone.0303537 DOI
14. Marshall S, Tardif G, Ashworth N. Local corticosteroid injection for carpal tunnel syndrome. Cochrane Database Syst Rev. 2007 Apr
18;(2):CD001554. doi: 10.1002/14651858.CD001554.pub2. DOI
15. Ashworth NL, Bland JDP, Chapman KM, Tardif G, Albarqouni L, Nagendran A. Local corticosteroid injection versus placebo for carpal tunnel
syndrome. Cochrane Database Syst Rev. 2023 Feb 1;2(2):CD015148. doi: 10.1002/14651858.CD015148 DOI
16. Kaile E, Bland JDP. Safety of corticosteroid injection for carpal tunnel syndrome. J Hand Surg Eur Vol. 2018 Mar;43(3):296-302. doi:
10.1177/1753193417734426 DOI
17. Dong C, Zhu Y, Zhou J, Dong L, Hu L. Comparison of distal and proximal local steroid injection for carpal tunnel syndrome: a systematic review
and meta-analysis of randomized controlled trials. Pain Ther. 2022 Dec;11(4):1389-1402. doi: 10.1007/s40122-022-00444-3 DOI
18. Manente GTF, Di Blasio F, Staniscia T, Romano F, Uncini A. An innovative hand brace for carpal tunnel syndrome: a randomized controlled
trial. Muscle Nerve. 2001;24(8):1020-5. DOI
19. D eAngelis MV, Di Giovanni P, Staniscia T, Uncini A. Ecacy of a sof t hand brace and a wrist splint for carpal tunnel syndrome: a randomized
controlled study. Acta Neurol Scand. 2009;119(1):68-74. DOI
Andrzej Żyluk, Alicja Żyluk
2544
20. PageMJ, O’Connor D, Pitt V. Splinting for carpal tunnel syndrome. Cochrane Database Syst Rev. 2012;11(7):CD010003
21. Ostergaard PJ, Meyer MA, Earp BE. Non-operative treatment of carpal tunnel syndrome. Curr Rev Musculoskelet Med. 2020 Apr;13(2):141-
147. doi: 10.1007/s12178-020-09616-0. DOI
22. Lusa V, Karjalainen TV, Pääkkönen M, Rajamäki TJ, Jaatinen K. Surgical versus non-surgical treatment for carpal tunnel syndrome. Cochrane
Database Syst Rev. 2024 Jan 8;1(1):CD001552. doi: 10.1002/14651858.CD001552.pub3 DOI
23. Karjalainen TV, Lusa V, Page MJ, O’Connor D, Massy-Westropp N, Peters SE. Splinting for carpal tunnel syndrome. Cochrane Database Syst
Rev. 2023 Feb 27;2(2):CD010003. doi: 10.1002/14651858.CD010003.pub2 DOI
24. Çatalbas N, Akkaya N, Atalay NS, Sahin F. Ultrasonographic imaging of the eects of continuous, pulsed or sham ultrasound treatments
on carpal tunnel syndrome: A randomized controlled study. J Back Musculoskelet Rehabil. 2018;31:981-989.
25. Weintraub MI. Non-invasive laser neurolysis in carpal tunnel syndrome. Muscle Nerve. 1997 Aug;20(8):1029-31. doi: 10.1002/(sici)1097-
4598(199708)20:8<1029::aid-mus14>3.0.co;2-q DOI
26. Li ZJ, Wang Y, Zhang HF, Ma XL, Tian P, Huang Y. Eectiveness of low-level laser on carpal tunnel syndrome: A meta-analysis of previously
reported randomized trials. Medicine (Baltimore). 2016 Aug;95(31):e4424. doi: 10.1097/MD.0000000000004424. DOI
27. Ebenbichler GR, Resch KL, Nicolakis P, Wiesinger GF, Uhl F, Ghanem AH, Fialka V. Ultrasound treatment for treating the carpal tunnel
syndrome: randomised “sham” controlled trial. BMJ. 1998 Mar 7;316(7133):731-5. doi: 10.1136/bmj.316.7133.731 DOI
28. Page MJ, O’Connor D, Pitt V, Massy-Westropp N. Therapeutic ultrasound for carpal tunnel syndrome. Cochrane Database Syst Rev. 2013
Mar 28;2013(3):CD009601. doi: 10.1002/14651858.CD009601.pub2 DOI
29. Chung VCH, Ho RST, Liu S, Chong MKC, Leung AWN, Yip BHK. Electroacupuncture and splinting versus splinting alone to treat carpal
tunnel syndrome: A randomized controlled trial. Can. Med. Assoc. J. 2016, 188, 867-875. DOI
30. Li T, Yan J, Hu J, Liu X, Wang F. Ecacy and safety of electroacupuncture for carpal tunnel syndrome (CTS): A systematic review and
meta-analysis of randomized controlled trials. Front Surg. 2022 Sep 23;9:952361. doi: 10.3389/fsurg.2022.952361 DOI
31. Choi GH, Wieland LS, Lee H, Sim H, Lee MS, Shin BC. Acupuncture and related interventions for the treatment of symptoms associated
with carpal tunnel syndrome. Cochrane Database Syst Rev. 2018 Dec 2;12(12):CD011215. doi: 10.1002/14651858.CD011215.pub2 DOI
32. Ambroziak M. Application of ESWT in post-operative treatment in carpal tunnel syndrome – a review. Pol Przegl Chir. 2020 Apr 16;92(3):39-
43. doi: 10.5604/01.3001.0014.0947. DOI
33. Xu D, Ma W, Jiang W, Hu X, Jiang F, Mao C, Wang Y, Fang L, Luo N, Li H, Lou Z, Gan K. A randomized controlled trial: comparing extracorporeal
shock wave therapy versus local corticosteroid injection for the treatment of carpal tunnel syndrome. Int Orthop. 2020 Jan;44(1):141-
146. doi: 10.1007/s00264-019-04432-9 DOI
34. Kim JC, Jung SH, Lee SU, Lee SY. Eect of extracorporeal shockwave therapy on carpal tunnel syndrome: A systematic review and meta-
analysis of randomized controlled trials. Medicine (Baltimore). 2019 Aug;98(33):e16870. doi: 10.1097/MD.0000000000016870 DOI
35. Chen KT, Chen YP, Kuo YJ, Chiang MH. Extracorporeal shock wave therapy provides limited therapeutic eects on carpal tunnel syndrome:
a systematic review and meta-analysis. Medicina (Kaunas). 2022 May 19;58(5):677. doi: 10.3390/medicina58050677 DOI
36. Incebiyik S, Boyaci A, Tutoglu A. Short-term eectiveness of short-wave diathermy treatment on pain, clinical symptoms, and hand
function in patients with mild or moderate idiopathic carpal tunnel syndrome. J Back Musculoskelet Rehabil. 2015;28(2):221-8. doi:
10.3233/BMR-140507 DOI
37 . Pollet J, Ranica G, Pedersini P, Lazzarini SG, Pancera S, Buraschi R. The ecacy of electromagnetic diathermy for the treatment of musculoskeletal
disorders: a systematic review with meta-analysis. J Clin Med. 2023 Jun 9;12(12):3956. doi: 10.3390/jcm12123956 DOI
38. B ueno-Gracia E, Ruiz-de-Escudero-Zapico A, Malo-Urriés M, et al. Dimensional changes of the carpal tunnel and the median nerve during
manual mobilization of the carpal bones. Musculoskelet Sci Pract. 2018 Aug;36:12-16. doi: 10.1016/j.msksp.2018.04.002 DOI
39. Akalin EEO, Peker O, Senocak O, et al. Treatment of carpal tunnel syndrome with nerve and tendon gliding exercises. Am J Phys Med
Rehabil. 2002;81(2):108-13. DOI
40. Page MJ, O’Connor D, Pitt V, Massy-Westropp N. Exercise and mobilisation interventions for carpal tunnel syndrome. Cochrane Database
Syst Rev. 2012 Jun 13;(6):CD009899. doi: 10.1002/14651858.CD009899 DOI
41. Geler Külcü D, Bursali C, Aktaş İ, Bozkurt Alp S, Ünlü Özkan F, Akpinar P. Kinesiotaping as an alternative treatment method for carpal
tunnel syndrome. Turk J Med Sci. 2016 Jun 23;46(4):1042-9. doi: 10.3906/sag-1503-4 DOI
42. Krause D, Roll SC, Javaherian-Dysinger H, Daher N. Comparative ecacy of the dorsal application of Kinesio tape and splinting for carpal
tunnel syndrome: A randomized controlled trial. J Hand Ther. 2021 Jul-Sep;34(3):351-361. doi: 10.1016/j.jht.2020.03.010 DOI
CONFLICT OF INTEREST
The Authors declare no conict of interest
Eectiveness of non-operative methods of treatment of carpal tunnel syndrome: a narrative review
2545
CORRESPONDING AUTHOR
Andrzej Żyluk
Klinika Chirurgii Ogólnej i Chirurgii Ręki
Pomorski Uniwersytet Medyczny,
ul. Unii Lubelskiej 1, 71-252, Szczecin, Poland
email: azyluk@hotmail.com
ORCID AND CONTRIBUTIONSHIP
Andrzej Żyluk: 0000-0002-8299-4525
Żyluk Alicja: 0009-0006-0309-0568
Work concept and design, – Data collection and analysis, – Responsibility for statistical analysis, – Writing the article, – Critical review, – Final approval of the article
RECEIVED: 10.07.2024
ACCEPTED: 15.11.2024
CREATIVE COMMONS 4.0
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
Various injectants are available for the treatment of carpal tunnel syndrome. This systematic review and network meta-analysis was conducted to investigate the effectiveness of different injection therapies in alleviating the symptoms of carpal tunnel syndrome. Various databases were searched for relevant studies from inception until May 10, 2023. Eligible studies were identified using the patient (P), intervention (I), comparison (C), and outcomes (O) model, which involved (P) participants with carpal tunnel syndrome, (I) an intervention based on injection therapy, (C) the use of placebo or another injectant as a control treatment, and (O) the measurement of clinical and electrodiagnostic outcomes of interest. A total of 18 studies were included in the analysis. The network meta-analysis revealed that platelet-rich plasma is effective in the treatment of carpal tunnel syndrome in terms of symptom and pain relief and functional improvement in both the short and long term, whereas steroids are effective only in the short term. Additionally, injections of dextrose solution may offer long-term pain relief as well as short- and long-term symptom alleviation and functional improvement. The study findings suggest that platelet-rich plasma should be used as the first-line treatment for carpal tunnel syndrome, with dextrose and steroids serving as alternative treatment options.
Article
Full-text available
Objective: This study aims to establish the effect of electromagnetic diathermy therapies (e.g., shortwave, microwave, capacitive resistive electric transfer) on pain, function, and quality of life in treating musculoskeletal disorders. Methods: We conducted a systematic review according to the PRISMA statement and Cochrane Handbook 6.3. The protocol has been registered in PROSPERO: CRD42021239466. The search was conducted in PubMed, PEDro, CENTRAL, EMBASE, and CINAHL. Results: We retrieved 13,323 records; 68 studies were included. Many pathologies were treated with diathermy against placebo, as a standalone intervention or alongside other therapies. Most of the pooled studies did not show significant improvements in the primary outcomes. While the analysis of single studies shows several significant results in favour of diathermy, all comparisons considered had a GRADE quality of evidence between low and very low. Conclusions: The included studies show controversial results. Most of the pooled studies present very low quality of evidence and no significant results, while single studies have significant results with a slightly higher quality of evidence (low), highlighting a critical lack of evidence in the field. The results did not support the adoption of diathermy in a clinical context, preferring therapies supported by evidence.
Article
Full-text available
Carpal tunnel syndrome (CTS) is the most common peripheral entrapment, and recently, ultrasound-guided perineural injection (UPIT) and percutaneous flexor retinaculum release (UPCTR) have been utilized to treat CTS. However, no systematic review or meta-analysis has included both intervention types of ultrasound-guided interventions for CTS. Therefore, we performed this review using four databases (i.e., PubMed, EMBASE, Scopus, and Cochrane) to evaluate the quality of evidence, effectiveness, and safety of the published studies on ultrasound-guided interventions in CTS. Among sixty studies selected for systemic review, 20 randomized treatment comparison or controlled studies were included in six meta-analyses. Steroid UPIT with ultrasound guidance outperformed that with landmark guidance. UPIT with higher-dose steroids outperformed that with lower-dose steroids. UPIT with 5% dextrose in water (D5W) outperformed control injection and hydrodissection with high-volume D5W was superior to that with low-volume D5W. UPIT with platelet-rich plasma outperformed various control treatments. UPCTR outperformed open surgery in terms of symptom improvement but not functional improvement. No serious adverse events were reported in the studies reviewed. The findings suggest that both UPIT and UPCTR may provide clinically important benefits and appear safe. Further treatment comparison studies are required to determine comparative therapeutic efficacy.
Article
Full-text available
IntroductionLocal steroid injection (LSI) in the carpal tunnel is a mainstay of conservative treatment in patients with carpal tunnel syndrome (CTS). Currently, clinicians generally perform a conventional proximal approach (PA) or novel distal approach (DA) for LSI. Recent systematic reviews comparing the two injection methods are lacking. This systematic review and meta-analysis aimed to assess whether LSI using the DA was superior to PA in treating patients with CTS.Methods Databases including Pubmed, Embase, and the Cochrane library were searched up to 30 May 2022 to identify relevant randomized controlled trials (RCTs) comparing the DA with the PA steroid injection in patients with CTS. The outcomes mainly included Boston Carpal Tunnel Questionnaire Symptom Severity Scale (BCTQs) and Functional Status Scale (BCTQf), visual analog scores (VAS), electrophysiological outcomes, pain of injection, duration of injection, or adverse events.ResultsFive RCTs involving 339 patients were identified. Pooled analysis showed that the DA group took less time [mean difference (MD) −19.91; 95% CI −34.48 to −5.35; P = 0.007] and acquired better sensory nerve action potential amplitude [standardized mean difference (SMD) −0.37; 95% CI −0.62 to −0.11; P = 0.005]. The two groups were not significantly different in terms of BCTQs and BCTQf, VAS, other electrophysiological outcomes, pain of injection, or adverse events (P > 0.05).Conclusion Although providing similar improvement in pain relief or function improvement, the distal approach is superior to the proximal approach in terms of timing, without increasing other side effects. Further high-quality randomized studies are required to confirm these results.
Article
Full-text available
Aim We carried out a systematic review and meta-analysis to evaluate the safety and efficacy of electroacupuncture for patients with carpal tunnel syndrome. Methods We searched PubMed, Embase, Cochrane Library, Scopus, Web of Science, Chinese National Knowledge Infrastructure (CNKI), Chongqing VIP Database (VIP), and Wan Fang Database up to May 2022 for relevant studies. Relevant studies were identified by using specific eligibility criteria and data were extracted. Results A total of 26 randomized controlled trials (RCTs) with 1,698 patients were included. Compared with routine treatment, electroacupuncture treatment had lower visual analog scale (VAS) score [mean difference = −0.79, 95% confidence interval (CI): −1.11 to −0.47, P < 0.00001], and the symptom severity scale and function status scale in electroacupuncture group were significantly lower than the control group ( P = 0.0001 and P = 0.006). Moreover, the electrophysiological parameters in the electroacupuncture group were better than the control group. The electroacupuncture group had higher total effective rate than the control group (odds ratio = 4.94, 95% CI: 3.44–7.08, P < 0.00001). Conclusion Our meta-analysis indicated that electroacupuncture had lower VAS score, higher total effective rate, a lower the scores of symptoms and function and electroacupuncture had better electrophysiological parameters. However, these findings needed to be verified further by multicenter, double-blind, and large-sample RCTs.
Article
Full-text available
Night wrist splinting has been a conservative treatment for carpal tunnel syndrome. The addition of extracorporeal shock wave therapy provides an alternative treatment. However, strong evidence on the clinical effectiveness of extracorporeal shock wave therapy for carpal tunnel syndrome is still lacking. This study aimed to investigate the effectiveness and safety of extracorporeal shock wave therapy compared with treatments of night wrist splints alone for patients with carpal tunnel syndrome. In this systematic review and meta-analysis, no limitation criteria were used for study selection. All available articles that compare the effectiveness between extracorporeal shock wave therapy combined with night wrist splint and night wrist splint alone for treating carpal tunnel syndrome published up to 20 January 2022 were identified from the databases of PubMed, Embase, and Cochrane Central Register of Controlled Trials Central. The primary outcomes were a standard mean difference with a 95% confidence interval on the improvement of symptom severity and functional impairment between the two groups. In an attempt to analyze trends over time in studies that report repeated measurements, an all time-points meta-analysis (ATM) was undertaken. Seven randomized controlled trials with a total of 376 participants were included in this study. Significant improvements in functional impairment and symptom remission were only observed in the extracorporeal shock wave group at four weeks post-treatment. Extracorporeal shock wave therapy did not demonstrate superior efficacy compared to treatment with night wrist splint alone at 8–10 and 12–14 weeks post-treatment, or through the ATM approach. In conclusion, the therapeutic effect of extracorporeal shock wave therapy is transient and mostly nonsignificant compared with using night wrist splint alone. No serious side effects were reported in all included studies. Other conservative treatments to ameliorate carpal tunnel syndrome symptoms are warranted.
Article
Full-text available
Background: Peripheral nerve entrapment syndromes commonly result in pain, discomfort, and ensuing sensory and motor impairment. Many conservative measures have been proposed as treatment, local injection being one of those measures. Now with high-resolution ultrasound, anatomical details can be visualized allowing diagnosis and more accurate injection treatment. Ultrasound-guided injection technique using a range of injectates to mechanically release and decompress the entrapped nerves has therefore developed called hydrodissection or perineural injection therapy. Several different injectates from normal saline, local anesthetics, corticosteroids, 5% dextrose in water (D5W), and platelet-rich plasma (PRP) are available and present clinical challenges when selecting agents regarding effectiveness and safety. Aims: To systematically search and summarize the clinical evidence and mechanism of different commonly used injectates for ultrasound-guided hydrodissection entrapment neuropathy treatment. Methods: Four databases, including PubMed, EMBASE, Scopus, and Cochrane were systematically searched from the inception of the database up to August 22, 2020. Studies evaluating the effectiveness and safety of different commonly used injectates for ultrasound-guided hydrodissection entrapment neuropathy treatment were included. Injectate efficacy presents clinical effects on pain intensity, clinical symptoms/function, and physical performance, electrodiagnostic findings, and nerve cross-sectional areas. Safety outcomes and mechanism of action of each injectate were also described. Results: From ten ultrasound-guided hydrodissection studies, nine studies were conducted in carpal tunnel syndrome and one study was performed in ulnar neuropathy at the elbow. All studies compared different interventions with different comparisons. Injectates included normal saline, D5W, corticosteroids, local anesthetics, hyaluronidase, and PRP. Five studies investigated PRP or PRP plus splinting comparisons. Both D5W and PRP showed a consistently favorable outcome than those in the control group or corticosteroids. The improved outcomes were also observed in comparison groups using injections with normal saline, local anesthetics, or corticosteroids, or splinting. No serious adverse events were reported. Local steroid injection side effects were reported in only one study. Conclusion: Ultrasound-guided hydrodissection is a safe and effective treatment for peripheral nerve entrapment. Injectate selection should be considered based on the injectate mechanism, effectiveness, and safety profile.
Article
Background: Carpal tunnel syndrome (CTS) is a compression neuropathy of the median nerve at the wrist. Surgery is considered when symptoms persist despite the use of non-surgical treatments. It is unclear whether surgery produces a better outcome than non-surgical therapy. This is an update of a Cochrane review published in 2008. Objectives: To assess the evidence regarding the benefits and harms of carpal tunnel release compared with non-surgical treatment in the short (< 3 months) and long (> 3 months) term. Search methods: In this update, we included studies from the previous version of this review and searched the Cochrane Neuromuscular Specialised Register, CENTRAL, Embase, MEDLINE, ClinicalTrials.gov and WHO ICTRP until 18 November 2022. We also checked the reference lists of included studies and relevant systematic reviews for studies. Selection criteria: We included randomised controlled trials comparing any surgical technique with any non-surgical therapies for CTS. Data collection and analysis: We used the standard methodological procedures expected by Cochrane. Main results: The 14 included studies randomised 1231 participants (1293 wrists). Eighty-four per cent of participants were women. The mean age ranged from 32 to 53 years, and the mean duration of symptoms from 31 weeks to 3.5 years. Trial sizes varied from 22 to 176 participants. The studies compared surgery with: splinting, corticosteroid injection, splinting and corticosteroid injection, platelet-rich plasma injection, manual therapy, multimodal non-operative treatment, unspecified medical treatment and hand support, and surgery and corticosteroid injection with corticosteroid injection alone. Since surgery is generally used for its long-term effects, this abstract presents only long-term results for surgery versus splinting and surgery versus corticosteroid injection. 1) Surgery compared to splinting in the long term (> 3 months) Surgery probably results in a higher rate of clinical improvement (risk ratio (RR) 2.10, 95% confidence interval (CI) 1.04 to 4.24; 3 studies, 210 participants; moderate-certainty evidence). Surgery probably does not provide clinically important benefit in symptoms or hand function compared with splinting (moderate-certainty evidence). The mean Boston Carpal Tunnel Questionnaire (BCTQ) Symptom Severity Scale (scale 1 to 5; higher is worse; minimal clinically important difference (MCID) = 1) was 1.54 with splint and 0.26 points better with surgery (95% CI 0.52 better to 0.01 worse; 2 studies, 195 participants). The mean BCTQ Functional Status Scale (scale 1 to 5; higher is worse; MCID 0.7) was 1.75 with splint and 0.36 points better with surgery (95% CI 0.62 better to 0.09 better; 2 studies, 195 participants). None of the studies reported pain. Surgery may not provide better health-related quality of life compared with splinting (low-certainty evidence). The mean EQ-5D index (scale 0 to 1; higher is better; MCID 0.074) was 0.81 with splinting and 0.04 points better with surgery (95% CI 0.0 to 0.08 better; 1 study, 167 participants). We are uncertain about the risk of adverse effects (very low-certainty evidence). Adverse effects were reported amongst 60 of 98 participants (61%) in the surgery group and 46 of 112 participants (41%) in the splinting group (RR 2.11, 95% CI 0.37 to 12.12; 2 studies, 210 participants). Surgery probably reduces the risk of further surgery; 41 of 93 participants (44%) were referred to surgery in the splinting group and 0 of 83 participants (0%) repeated surgery in the surgery group (RR 0.03, 95% CI 0.00 to 0.21; 2 studies, 176 participants). This corresponds to a number needed to treat for an additional beneficial outcome (NNTB) of 2 (95% CI 1 to 9). 2) Surgery compared to corticosteroid injection in the long term (> 3 months) We are uncertain if clinical improvement or symptom relief differs between surgery and corticosteroid injection (very low-certainty evidence). The RR for clinical improvement was 1.23 (95% CI 0.73 to 2.06; 3 studies, 187 participants). For symptoms, the standardised mean difference (SMD) was -0.60 (95% CI -1.88 to 0.69; 2 studies, 118 participants). This translates to 0.4 points better (95% CI from 1.3 better to 0.5 worse) on the BCTQ Symptom Severity Scale. Hand function or pain probably do not differ between surgery and corticosteroid injection (moderate-certainty evidence). For function, the SMD was -0.12 (95% CI -0.80 to 0.56; 2 studies, 191 participants) translating to 0.10 points better (95% CI 0.66 better to 0.46 worse) on the BCTQ Functional Status Scale with surgery. Pain (0 to 100 scale) was 8 points with corticosteroid injection and 6 points better (95% CI 10.45 better to 1.55 better; 1 study, 123 participants) with surgery. We found no data to estimate the difference in health-related quality of life (very low-certainty evidence). We are uncertain about the risk of adverse effects and further surgery (very low-certainty evidence). Adverse effects were reported amongst 3 of 45 participants (7%) in the surgery group and 2 of 45 participants (4%) in the corticosteroid injection group (RR 1.49, 95% CI 0.25 to 8.70; 2 studies, 90 participants). In one study, 12 of 83 participants (15%) needed surgery in the corticosteroid group, and 7 of 80 participants (9%) needed repeated surgery in the surgery group (RR 0.61, 95% CI 0.25 to 1.46; 1 study, 163 participants). Authors' conclusions: Currently, the efficacy of surgery in people with CTS is unclear. It is also unclear if the results can be applied to people who are not satisfied after trying various non-surgical options. Future studies should preferably blind participants from treatment allocation and randomise people who are dissatisfied after being treated non-surgically. The decision for a patient to opt for surgery should balance the small benefits and potential risks of surgery. Patients with severe symptoms, a high preference for clinical improvement and reluctance to adhere to non-surgical options, and who do not consider potential surgical risks and morbidity a burden, may choose surgery. On the other hand, those who have tolerable symptoms, who have not tried non-surgical options and who want to avoid surgery-related morbidity can start with non-surgical options and have surgery only if necessary. We are uncertain if the risk of adverse effects differs between surgery and non-surgical treatments. The severity of adverse effects may also be different.
Article
Background: Carpal tunnel syndrome (CTS) is a compression neuropathy of the median nerve causing pain and numbness and tingling typically in the thumb, index and middle finger. It sometimes results in muscle wasting, diminished sensitivity and loss of dexterity. Splinting the wrist (with or without the hand) using an orthosis is usually offered to people with mild-to-moderate findings, but its effectiveness remains unclear. Objectives: To assess the effects (benefits and harms) of splinting for people with CTS. Search methods: On 12 December 2021, we searched the Cochrane Neuromuscular Specialised Register, CENTRAL, MEDLINE, Embase, AMED, CINAHL, ClinicalTrials.gov, and WHO ICTRP with no limitations. We checked the reference lists of included studies and relevant systematic reviews for studies. Selection criteria: Randomised trials were included if the effect of splinting could be isolated from other treatment modalities. The comparisons included splinting versus no active treatment (or placebo), splinting versus another disease-modifying non-surgical treatment, and comparisons of different splint-wearing regimens. We excluded studies comparing splinting with surgery or one splint design with another. We excluded participants if they had previously undergone surgical release. Data collection and analysis: Review authors independently selected trials for inclusion, extracted data, assessed study risk of bias and the certainty in the body of evidence for primary outcomes using the GRADE approach, according to standard Cochrane methodology. Main results: We included 29 trials randomising 1937 adults with CTS. The trials ranged from 21 to 234 participants, with mean ages between 42 and 60 years. The mean duration of CTS symptoms was seven weeks to five years. Eight studies with 523 hands compared splinting with no active intervention (no treatment, sham-kinesiology tape or sham-laser); 20 studies compared splinting (or splinting delivered along with another non-surgical intervention) with another non-surgical intervention; and three studies compared different splinting regimens (e.g. night-time only versus full time). Trials were generally at high risk of bias for one or more domains, including lack of blinding (all included studies) and lack of information about randomisation or allocation concealment in 23 studies. For the primary comparison, splinting compared to no active treatment, splinting may provide little or no benefits in symptoms in the short term (< 3 months). The mean Boston Carpal Tunnel Questionnaire (BCTQ) Symptom Severity Scale (SSS) (scale 1 to 5, higher is worse; minimal clinically important difference (MCID) 1 point) was 0.37 points better with splint (95% confidence interval (CI) 0.82 better to 0.08 worse; 6 studies, 306 participants; low-certainty evidence) compared with no active treatment. Removing studies with high or unclear risk of bias due to lack of randomisation or allocation concealment supported our conclusion of no important effect (mean difference (MD) 0.01 points worse with splint; 95% CI 0.20 better to 0.22 worse; 3 studies, 124 participants). In the long term (> 3 months), we are uncertain about the effect of splinting on symptoms (mean BCTQ SSS 0.64 better with splinting; 95% CI 1.2 better to 0.08 better; 2 studies, 144 participants; very low-certainty evidence). Splinting probably does not improve hand function in the short term and may not improve hand function in the long term. In the short term, the mean BCTQ Functional Status Scale (FSS) (1 to 5, higher is worse; MCID 0.7 points) was 0.24 points better (95% CI 0.44 better to 0.03 better; 6 studies, 306 participants; moderate-certainty evidence) with splinting compared with no active treatment. In the long term, the mean BCTQ FSS was 0.25 points better (95% CI 0.68 better to 0.18 worse; 1 study, 34 participants; low-certainty evidence) with splinting compared with no active treatment. Night-time splinting may result in a higher rate of overall improvement in the short term (risk ratio (RR) 3.86, 95% CI 2.29 to 6.51; 1 study, 80 participants; number needed to treat for an additional beneficial outcome (NNTB) 2, 95% CI 2 to 2; low-certainty evidence). We are uncertain if splinting decreases referral to surgery, RR 0.47 (95% CI 0.14 to 1.58; 3 studies, 243 participants; very low-certainty evidence). None of the trials reported health-related quality of life. Low-certainty evidence from one study suggests that splinting may have a higher rate of adverse events, which were transient, but the 95% CIs included no effect. Seven of 40 participants (18%) reported adverse effects in the splinting group and 0 of 40 participants (0%) in the no active treatment group (RR 15.0, 95% CI 0.89 to 254.13; 1 study, 80 participants). There was low- to moderate-certainty evidence for the other comparisons: splinting may not provide additional benefits in symptoms or hand function when given together with corticosteroid injection (moderate-certainty evidence) or with rehabilitation (low-certainty evidence); nor when compared with corticosteroid (injection or oral; low certainty), exercises (low certainty), kinesiology taping (low certainty), rigid taping (low certainty), platelet-rich plasma (moderate certainty), or extracorporeal shock wave treatment (moderate certainty). Splinting for 12 weeks may not be better than six weeks, but six months of splinting may be better than six weeks of splinting in improving symptoms and function (low-certainty evidence). Authors' conclusions: There is insufficient evidence to conclude whether splinting benefits people with CTS. Limited evidence does not exclude small improvements in CTS symptoms and hand function, but they may not be clinically important, and the clinical relevance of small differences with splinting is unclear. Low-certainty evidence suggests that people may have a greater chance of experiencing overall improvement with night-time splints than no treatment. As splinting is a relatively inexpensive intervention with no plausible long-term harms, small effects could justify its use, particularly when patients are not interested in having surgery or injections. It is unclear if a splint is optimally worn full time or at night-time only and whether long-term use is better than short-term use, but low-certainty evidence suggests that the benefits may manifest in the long term.
Article
Background: Carpal tunnel syndrome (CTS) is a very common clinical syndrome manifested by signs and symptoms of irritation of the median nerve at the carpal tunnel in the wrist. Direct and indirect costs of CTS are substantial, with estimated costs of two billion US dollars for CTS surgery in the USA in 1995 alone. Local corticosteroid injection has been used as a non-surgical treatment for CTS many years, but its effectiveness is still debated. Objectives: To evaluate the benefits and harms of corticosteroids injected in or around the carpal tunnel for the treatment of carpal tunnel syndrome compared to no treatment or a placebo injection. Search methods: We used standard, extensive Cochrane search Methods. The searches were 7 June 2020 and 26 May 2022. Selection criteria: We included randomised controlled trials (RCTs) or quasi-randomised trials of adults with CTS that included at least one comparison group of local injection of corticosteroid (LCI) into the wrist and one group that received a placebo or no treatment. Data collection and analysis: We used standard Cochrane methods. Our primary outcome was 1. improvement in symptoms at up to three months of follow-up. Our secondary outcomes were 2. functional improvement, 3. improvement in symptoms at greater than three months of follow-up, 4. improvement in neurophysiological parameters, 5. improvement in imaging parameters, 6. requirement for carpal tunnel surgery, 7. improvement in quality of life and 8. Adverse events: We used GRADE to assess the certainty of evidence for each outcome. Main results: We included 14 trials with 994 participants/hands with CTS. Only nine studies (639 participants/hands) had useable data quantitatively and in general, these studies were at low risk of bias except for one quite high-risk study. The trials were conducted in hospital-based clinics across North America, Europe, Asia and the Middle East. All trials used participant-reported outcome measures for symptoms, function and quality of life. There is probably an improvement in symptoms measured at up to three months of follow-up favouring LCI (standardised mean difference (SMD) -0.77, 95% confidence interval (CI) -0.94 to -0.59; 8 RCTs, 579 participants; moderate-certainty evidence). Up to six months this was still evident favouring LCI (SMD -0.58, 95% CI -0.89 to -0.28; 4 RCTs, 234 participants/hands; moderate-certainty evidence). There is probably an improvement in function measured at up to three months favouring LCI (SMD -0.62, 95% CI -0.87 to -0.38; 7 RCTs, 499 participants; moderate-certainty evidence). We are uncertain if there is a difference in median nerve DML at up to three months of follow-up (mean difference (MD) -0.37 ms, 95% CI -0.75 to 0.02; 6 RCTs, 359 participants/hands; very low-certainty evidence). The requirement for surgery probably reduces slightly in the LCI group at one year (risk ratio 0.84, 95% CI 0.72 to 0.98; 1 RCT, 111 participants, moderate-certainty evidence). Quality of life, measured at up to three months of follow-up using the Short-Form 6 Dimensions questionnaire (scale from 0.29 to 1.0; higher is better) probably improved slightly in the LCI group (MD 0.07, 95% CI 0.02 to 0.12; 1 RCT, 111 participants; moderate-certainty evidence). Adverse events were uncommon (low-certainty evidence). One study reported 2/364 injections resulted in severe pain which resolved over "several weeks" and 1/364 injections caused a "sympathetic reaction" with a cool, pale hand that completely resolved in 20 minutes. One study (111 participants) reported no serious adverse events, but 65% of LCI-injected and 16% of the placebo-injected participants experienced mild-to-moderate pain lasting less than two weeks. About 9% of participants experienced localised swelling lasting less than two weeks. Four studies (229 participants) reported that they experienced no adverse events in their studies. Three studies (220 participants) did not specifically report adverse events. Authors' conclusions: Local corticosteroid injection is effective for the treatment of mild and moderate CTS with benefits lasting up to six months and a reduced need for surgery up to 12 months. Where serious adverse events were reported, they were rare.